Radiology Partners announced on August 25 a definitive agreement to buy Everlight Radiology, the London-based firm that ranks among the world’s largest teleradiology operations. The American group did not disclose financial terms, but the Australian Financial Review put the price at roughly $715 million, citing sources with knowledge of the agreement; parts of the trade press reported the transaction as a $1 billion deal. Whatever the final number, the effect is the same: the largest global remote-reading platform is being created, and radiology consolidation stops being an American phenomenon.
The numbers behind the deal
Everlight was founded in 2006 and bills itself as the leading international provider of remote reads, serving hospitals and imaging centers across the U.K., Ireland, Australia, New Zealand and South Africa. It employs more than 800 radiologists working in 40 countries and produces about 2.5 million reports annually.
The arithmetic implicit in those numbers is worth doing, because it explains the price. That is roughly 3,100 reports per radiologist per year — productivity consistent with a mature teleradiology operation. And at $715 million, the buyer is paying about $286 per recurring annual report. For comparison, the seller — British private equity firm Livingbridge — paid approximately $344 million for a majority stake in 2021. Five years on, the exit lands at close to twice that value.
On the other side of the table, Radiology Partners was founded in 2012, is headquartered in Nashville, Tennessee, and employed more than 4,000 radiologists prior to the deal, servicing over 3,400 client sites. The company already had a strong remote-reading footprint in the U.S.: it acquired vRad, America’s largest teleradiology group, as part of the $885 million purchase of Mednax’s imaging business line in 2020. The stated thesis is to combine vRad and its 500-plus physicians with Everlight.
The follow-the-sun model
The asset Everlight is selling is not just volume, it is time zones. The follow-the-sun model spreads radiologists across multiple time zones so that one country’s overnight reading happens during another’s business hours. A study ordered at 3 a.m. in Manchester is reported by someone in mid-afternoon in Australia — no night shift, no sleep deprivation, no cost of staffing 24 hours in every market.
It is an elegant answer to emergency radiology’s most persistent problem, and it explains why these operations command high multiples: they monetize the time-zone spread, a resource investment alone cannot replicate. Rich Whitney, chairman and CEO of Radiology Partners, went straight at it in his statement: “Everlight has an unmatched global network of subspecialty radiologists, built over 20 years. RP has likewise spent many years in teleradiology and built the clinical infrastructure and technology that supports radiologists at scale.”
Radiologist shortage is the engine of consolidation
The market rationale Radiology Partners presents is the same in Everlight’s countries as in the United States: there are not enough people to report the studies. In Australia, per government estimates cited in the announcement, the number of diagnostic imaging services delivered under the local Medicare program rose 40% over the last decade, and advanced imaging grew almost twice as fast as radiologist workforce supply.
That is the same pressure we have documented elsewhere: report turnaround time up 177% in a decade in the United States and the radiologist exodus from the VA system are symptoms of the same imbalance. When demand grows faster than specialist training, capital moves in to arbitrage the gap — and the fastest way to arbitrage it is to buy whoever already has the radiologists under contract. It is the same scale play we tracked in the multibillion-dollar Curium-Lantheus radiopharmaceutical negotiation: sectors with supply bottlenecks attract consolidation.
Mosaic Drafting: AI is part of the thesis, not an accessory
The technology piece of the announcement deserves attention. Radiology Partners said it plans to make Mosaic Drafting — a product of its Mosaic Clinical Technologies subsidiary that uses AI to create preliminary imaging reports — available to Everlight readers, subject to regulatory clearances in other countries.
That sentence carries the deal’s entire economic logic. If the scarce asset is radiologist hours, and AI raises the number of studies each radiologist can report per hour, then buying a base of 800 radiologists and applying a productivity multiplier to it is a double lever. The regulatory detail is not trivial, though: AI-generated preliminary reports are classified differently by the FDA, the U.K.’s MHRA, Australia’s TGA and Brazil’s Anvisa, and “subject to clearances” can mean years of difference between markets. Radiology Partners has itself asked publicly for more regulatory clarity — we covered the case when the company petitioned the FDA for clearer rules on imaging AI.
What changes for clients and radiologists
Nothing in the short term — that is what both companies say. Upon closing, each organization will continue serving the same markets and clients, with radiologists reading where they are licensed and credentialed. “For Everlight’s clients, day-to-day relationships, contacts and clinical workflows are unchanged, and the business will continue to be led by its current management team,” Radiology Partners emphasized.
Rob Anderson, global CEO of Everlight, reinforced the point: “We are thrilled to be joining Radiology Partners, a move that will provide our radiologists and our clients access to additional clinical depth, technology and investment at a scale that would take years to build alone. What will not change is what our clients value most: the same teams, the same standards and the same commitment to reporting every study quickly and accurately.”
The caveat on licensing and credentialing is not boilerplate. It is the legal boundary that keeps teleradiology from becoming pure wage arbitrage: the radiologist has to be licensed in the patient’s jurisdiction, which limits substituting local labor with cheaper labor elsewhere.
Regulatory risk and what it means locally
The deal remains subject to regulatory approvals and closing conditions across multiple jurisdictions. A transaction concentrating two of the world’s largest remote-reading providers tends to attract antitrust scrutiny, especially in the U.K. and Australia, where Everlight holds a meaningful position and the buyer ends up with little competition at equivalent scale. There is execution risk too: integrating 800 radiologists from five countries onto a single technology platform, with distinct credentialing rules, is not trivial.
For Brazil, the message is a market one. Domestic teleradiology is already consolidating, and the American deal reinforces the thesis that scale is the decisive competitive factor in this segment — whoever has more volume dilutes platform, quality and now AI costs. CFM Resolution 2,314/2022 and the requirement of local medical registration keep the Brazilian market relatively insulated from direct foreign reporting, but they do not insulate it from acquisition: nothing stops global groups from buying already-licensed local operators. Independent services competing only on price per report are the most exposed.
What to watch in coming months: antitrust decisions in the U.K. and Australia, the real country-by-country timetable for clearing Mosaic Drafting, and whether the confirmed closing price lands nearer the reported $715 million or the $1 billion figure. The gap between those two numbers is itself an indicator of how much the market is still calibrating the value of a radiologist hour.
